FGFR a promising druggable target in cancer: Molecular biology and new drugsRut Porta, Christian Rolfo, Tindara Franchina et al.|Critical Reviews in Oncology/Hematology|2017Cited by 203
Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal CancerFabio Catalano, Alberto Puccini, Stefania Sciallero et al.|Cancers|2022Cited by 42
Cancer in a drop: Advances in liquid biopsy in 2024Roberto Borea, Carolina Reduzzi, Erick Figueiredo Saldanha et al.|Critical Reviews in Oncology/Hematology|2025Cited by 31